Navegar

Colección

Datos Estadísticas

Lista de

tumor escape
8
"IRE1α–XBP1 controls T cell function in ovarian cancer by regulating mitochondrial activity" (2018) Song, M.;Sandoval, T.A.;Chae, C.-S. (...)Cubillos-Ruiz, J.R. Nature. 562(7727):423-428
"IRE1α–XBP1 controls T cell function in ovarian cancer by regulating mitochondrial activity" (2018) Song, M.;Sandoval, T.A.;Chae, C.-S. (...)Cubillos-Ruiz, J.R. Nature. 562(7727):423-428
"Thyroid hormones and their membrane receptors as therapeutic targets for T cell lymphomas" (2016) Cremaschi, G.A.;Cayrol, F.;Sterle, H.A. (...)Barreiro Arcos, M.L. Pharmacological Research. 109:55-63
"Vascular galectins: Regulators of tumor progression and targets for cancer therapy" (2013) Thijssen, V.L.; Rabinovich, G.A.; Griffioen, A.W. Cytokine and Growth Factor Reviews. 24(6):547-558
"Neuroblastoma triggers an immunoevasive program involving galectin-1-dependent modulation of T cell and dendritic cell compartments" (2012) Soldati, R.;Berger, E.;Zenclussen, A.C. (...)Fest, S. International Journal of Cancer. 131(5):1131-1141
"Overcoming the hurdles of tumor immunity by targeting regulatory pathways in innate and adaptive immune cells" (2010) Zwirner, N.W.; Croci, D.O.; Domaica, C.I.; Rabinovich, G.A. Current Pharmaceutical Design. 16(3):255-267
"Galectin-1 as a potential therapeutic target in autoimmune disorders and cancer" (2008) Salatino, M.;Croci, D.O.;Bianco, G.A. (...)Rabinovich, G.A. Expert Opinion on Biological Therapy. 8(1):45-57
"Dynamic cross-talk between tumor and immune cells in orchestrating the immunosuppressive network at the tumor microenvironment" (2007) Croci, D.O.;Zacarías Fluck, M.F.;Rico, M.J. (...)Scharovsky, O.G. Cancer Immunology, Immunotherapy. 56(11):1687-1700